{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:20Z","timestamp":1707524840725},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,17]]},"DOI":"10.7759\/cureus.32638","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:35:48Z","timestamp":1671294948000},"source":"Crossref","is-referenced-by-count":2,"title":["Essential Thrombocytosis in Patients &lt;40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked"],"prefix":"10.7759","author":[{"given":"Lisa","family":"Kok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura F","family":"Taverne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva C","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiel","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertus J","family":"Voogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liane","family":"Oosterom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul R","family":"Herrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remko S","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-021-01599-y","article-title":"The challenge of choosing in cardiovascular risk management","volume":"30","author":"Hoogeveen RM","year":"2022","unstructured":"Hoogeveen RM, Hanssen NM, Brouwer JR, et al.. The challenge of choosing in cardiovascular risk management. Neth Heart J. 2022, 30:47-57. 10.1007\/s12471-021-01599-y","journal-title":"Neth Heart J"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1975.03240210031015","article-title":"Myocardial infarction without atherosclerosis","volume":"231","author":"Cheitlin MD","year":"1975","unstructured":"Cheitlin MD, McAllister HA, de Castro CM. Myocardial infarction without atherosclerosis. JAMA. 1975, 231:951-9.","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.05.001","article-title":"Acute myocardial infarction in young individuals","volume":"95","author":"Gulati R","year":"2020","unstructured":"Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, Singh M. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020, 95:136-56. 10.1016\/j.mayocp.2019.05.001","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.03.002","article-title":"From vulnerable plaque to vulnerable patient--Part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report","volume":"98","author":"Naghavi M","year":"2006","unstructured":"Naghavi M, Falk E, Hecht HS, et al.. From vulnerable plaque to vulnerable patient--Part III: executive summary of the screening for heart attack prevention and education (SHAPE) task force report. Am J Cardiol. 2006, 98:2H-15H. 10.1016\/j.amjcard.2006.03.002","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26377","article-title":"A population-based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series","volume":"96","author":"Smith CJ","year":"2021","unstructured":"Smith CJ, Thomas JW, Ruan G, et al.. A population-based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series. Am J Hematol. 2021, 96:E464-8. 10.1002\/ajh.26377","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv349","article-title":"Requiem for the 'vulnerable plaque'","volume":"36","author":"Libby P","year":"2015","unstructured":"Libby P, Pasterkamp G. Requiem for the 'vulnerable plaque'. Eur Heart J. 2015, 36:2984-7. 10.1093\/eurheartj\/ehv349","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi A","year":"2020","unstructured":"Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol. 2020, 95:1599-613. 10.1002\/ajh.26008","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05277.x","article-title":"Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia","volume":"128","author":"Elliott MA","year":"2005","unstructured":"Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2005, 128:275-90. 10.1111\/j.1365-2141.2004.05277.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1665640","article-title":"Percutaneous coronary intervention in patients with essential thrombocythemia: case reports and literature review","volume":"31","author":"Zheng Y","year":"2020","unstructured":"Zheng Y, Xu T, Chen L, Lin S, Chen S. Percutaneous coronary intervention in patients with essential thrombocythemia: case reports and literature review. Platelets. 2020, 31:815-9. 10.1080\/09537104.2019.1665640","journal-title":"Platelets"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.6095-20","article-title":"The assessment of the platelet function during the acute phase of ST-segment elevation myocardial infarction in essential thrombocythemia","volume":"60","author":"Kikuchi S","year":"2021","unstructured":"Kikuchi S, Hibi K, Tamura K, Kimura K. The assessment of the platelet function during the acute phase of ST-segment elevation myocardial infarction in essential thrombocythemia. Intern Med. 2021, 60:2639-43. 10.2169\/internalmedicine.6095-20","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui T","year":"2012","unstructured":"Barbui T, Finazzi G, Carobbio A, et al.. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood. 2012, 120:5128-33; quiz 5252. 10.1182\/blood-2012-07-444067","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20426","article-title":"Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female","volume":"32","author":"Bildirici U","year":"2009","unstructured":"Bildirici U, Celikyurt U, Ural E. Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female. Clin Cardiol. 2009, 32:104-5. 10.1002\/clc.20426","journal-title":"Clin Cardiol"},{"key":"ref13","article-title":"Practice guidelines for the therapy of essential thrombocythemia. a statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation","volume":"89","author":"Barbui T","year":"2004","unstructured":"Barbui T, Barosi G, Grossi A, et al.. Practice guidelines for the therapy of essential thrombocythemia. a statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica. 2004, 89:215-32.","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj AP","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006, 81:159-66. 10.4065\/81.2.159","journal-title":"Mayo Clin Proc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio A","year":"2011","unstructured":"Carobbio A, Thiele J, Passamonti F, et al.. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011, 117:5857-9. 10.1182\/blood-2011-02-339002","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00314.x","article-title":"Acute coronary disease in essential thrombocythemia and polycythemia vera","volume":"244","author":"Rossi C","year":"1998","unstructured":"Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med. 1998, 244:49-53. 10.1046\/j.1365-2796.1998.00314.x","journal-title":"J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano V","year":"2008","unstructured":"De Stefano V, Za T, Rossi E, et al.. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica. 2008, 93:372-80. 10.3324\/haematol.12053","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)91019-j","article-title":"Thrombocythemia and coronary artery disease","volume":"122","author":"Scheffer MG","year":"1991","unstructured":"Scheffer MG, Michiels JJ, Simoons ML, Roelandt JR. Thrombocythemia and coronary artery disease. Am Heart J. 1991, 122:573-6. 10.1016\/0002-8703(91)91019-j","journal-title":"Am Heart J"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux P","year":"1990","unstructured":"Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer. 1990, 66:549-56.","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90236.x","article-title":"Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area","volume":"65","author":"Jensen MK","year":"2000","unstructured":"Jensen MK, de Nully Brown P, Nielsen OJ, Hasselbalch HC. Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area. Eur J Haematol. 2000, 65:132-9. 10.1034\/j.1600-0609.2000.90236.x","journal-title":"Eur J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404693","article-title":"Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients","volume":"21","author":"Alvarez-Larr\u00e1n A","year":"2007","unstructured":"Alvarez-Larr\u00e1n A, Cervantes F, Bellosillo B, et al.. Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Leukemia. 2007, 21:1218-23. 10.1038\/sj.leu.2404693","journal-title":"Leukemia"},{"key":"ref22","article-title":"Essential thrombocythaemia as cause of myocardial infarction","volume":"9","author":"Derks A","year":"2001","unstructured":"Derks A, Bloemer MH. Essential thrombocythaemia as cause of myocardial infarction. Neth Heart J. 2001, 9:383-5.","journal-title":"Neth Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(84)91217-0","article-title":"Essential thrombocythaemia and recurrent myocardial infarction","volume":"1016","author":"Douste-Blazy P","year":"1984","unstructured":"Douste-Blazy P, Taudou MJ, Delay M, Pris J, Sie P, Ribaut L. Essential thrombocythaemia and recurrent myocardial infarction. Lancet. 1984, 1016:0140-6736. 10.1016\/s0140-6736(84)91217-0","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.31.2.268","article-title":"Myocardial infarction and multiple thromboses in a child with primary thrombocytosis","volume":"31","author":"Spach MS","year":"1963","unstructured":"Spach MS, Howell DA, Harris JS. . Myocardial infarction and multiple thromboses in a child with primary thrombocytosis. Pediatrics. 1963, 31:268-76. 10.1542\/peds.31.2.268","journal-title":"Pediatrics"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830330106","article-title":"Clinical manifestations of essential thrombocythemia in young adults","volume":"33","author":"Millard FE","year":"1990","unstructured":"Millard FE, Hunter CS, Anderson M, Edelman MJ, Kosty MP, Luiken GA, Marino GG. Clinical manifestations of essential thrombocythemia in young adults. Am J Hematol. 1990, 33:27-31. 10.1002\/ajh.2830330106","journal-title":"Am J Hematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005587","article-title":"Coronary embolism among ST-segment-elevation myocardial infarction patients: mechanisms and management","volume":"11","author":"Popovic B","year":"2018","unstructured":"Popovic B, Agrinier N, Bouchahda N, et al.. Coronary embolism among ST-segment-elevation myocardial infarction patients: mechanisms and management. Circ Cardiovasc Interv. 2018, 11:e005587. 10.1161\/CIRCINTERVENTIONS.117.005587","journal-title":"Circ Cardiovasc Interv"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa557","article-title":"Case report of an acute myocardial infarction after high-dose recreational nitrous oxide use: a consequence of hyperhomocysteinaemia?","volume":"5","author":"Oomens T","year":"2021","unstructured":"Oomens T, Riezebos RK, Amoroso G, Kuipers RS. Case report of an acute myocardial infarction after high-dose recreational nitrous oxide use: a consequence of hyperhomocysteinaemia?. Eur Heart J Case Rep. 2021, 5:ytaa557. 10.1093\/ehjcr\/ytaa557","journal-title":"Eur Heart J Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal S","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, et al.. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017, 377:111-21. 10.1056\/NEJMoa1701719","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49\u00a0488 individuals from the general population","volume":"160","author":"Nielsen C","year":"2013","unstructured":"Nielsen C, Birgens HS, Nordestgaard BG, Bojesen SE. Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49\u00a0488 individuals from the general population. Br J Haematol. 2013, 160:70-9. 10.1111\/bjh.12099","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2018-205527","article-title":"JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing","volume":"72","author":"Mahe E","year":"2019","unstructured":"Mahe E, Pedersen KM, \u00c7olak Y, et al.. JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing. J Clin Pathol. 2019, 72:172-6. 10.1136\/jclinpath-2018-205527","journal-title":"J Clin Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127610-essential-thrombocytosis-in-patients-40-years-old-with-acute-coronary-syndromes-a-not-so-uncommon-underlying-diagnosis-often-overlooked","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:20Z","timestamp":1707507980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127610-essential-thrombocytosis-in-patients-40-years-old-with-acute-coronary-syndromes-a-not-so-uncommon-underlying-diagnosis-often-overlooked"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.32638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,17]]}}}